At this event on World AIDS day, we will explore the different roles pharmacists can have in the prevention and screening of HIV infections, as well as in providing care and support to people living with HIV, namely through medication management. Other roles for pharmacists include HIV prevention through dispensing and providing support to preexposure prophylaxis (PrEP), HIV testing and harm reduction strategies for IV drugs users.

The World Health Organization estimates that around 38 million people live with HIV globally. Although there is still no cure for HIV, with the advancement of therapies and increasing access to effective HIV prevention, diagnosis, treatment and care, including for opportunistic infections, HIV infection has become a manageable chronic health condition, enabling people living with HIV to lead long and healthy lives.

Learning objectives:
1. Describe the burden and characteristics of HIV globally.
2. Understand the possibilities of involvement of pharmacists in the clinical care of people living with HIV.
3. Describe the role of pharmacists in PrEP-related services.

Moderator:
- Victoria Garcia Cardenas, FIP Pharmacy Practice Research SIG, Chair Senior Lecturer University of Technology Sydney, Australia / Spain

Panelists:
- Sham Moodley, FIP CPS Exco Member, Pharmacist Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa
- Nelli Barrière, Project Manager, HIV Programmes and Advocacy International AIDS Society, Switzerland
- Pilar Taberner Bonastre, Hospital pharmacist, Hospital Universitario Arnau de Vilanova, Lleida Spain
- Katrina F. Ortblad, Assistant Professor Fred Hutchinson Cancer Research Center, United States of America
- Tessa Oraro-Lawrence, Project Manager, HIV Programmes and Advocacy International AIDS Society, Switzerland

Para abogar por una implementación más amplia y armonizada de bioexenciones basadas en el sistema de clasificación biofarmacéutica (BCS) en los países de América Latina, la FIP está apoyando a los líderes regionales en la sensibilización sobre esta vía reguladora basada en la ciencia diseñada para acelerar la aprobación del mercado de productos farmacéuticos genéricos seguros y eficaces. La segunda parte de esta serie de seminarios web diseñados específicamente para la región de América Latina destaca ejemplos de vías de aprobación regulatoria de bioexenciones basadas en BCS que se implementan actualmente en países seleccionados de América Latina. Los expertos abordarán la base legislativa de las regulaciones de bioexenciones y discutirán las oportunidades de armonización dentro de la región.

Este webinar tiene los objetivos:

• Diferenciar entre la bioequivalencia in vivo y las estrategias reguladoras de bioexención basadas en BCS para la aprobación de medicamentos genéricos.
• Comprender las implicaciones para la salud pública de la vía reguladora de la bioexención basada en BCS.
• Delinear oportunidades y desafíos para la implementación de un proceso armonizado de aprobación regulatoria de bioexenciones dentro de la región de América Latina.
• Delinear las contribuciones de solubilidad, permeabilidad y disolución para aplicaciones de bioexención basadas en BCS.

Moderadora:
-Talita Ferreira, Coordinadora de Proyectos de bioexención en Latinoamérica FIP

Panelistas:
-Alfredo García Arieta, Jefe del Servicio de Farmacocinética y Medicamentos Genéricos AEMPS
-Andrés Figueroa Campos, Gerente SD Registro Sanitario de Productos Farmacéuticos Bioequivalentes
ANAMED ISPch–Agencia Nacional de Vigilancia Sanitaria de Chile
-Jorge Iliou, Dirección NVVS de Paraguay
-Alexis Aceituno,Jefe SD Registro Sanitario de Productos Farmacéuticos Bioequivalentes ANAMED ISPch–ANVSChile
-Miguel Angel Cabrera Prof. Asociado Central University of Las Villas

Summary:

Gastrointestinal symptoms have an impact on the health and wellbeing of individuals that can be debilitating, however, the majority of people can be supported by the pharmacy team to self-care and effectively manage their symptoms.

Aim: 

To explore: lifestyle factors that can cause or worsen gastrointestinal complaints and the role of pharmacy team in supporting the majority of customers to self-care and effectively manage their symptoms.

Learning objectives: 

1. List common GI symptoms and their impact on people;
2. Identify and suggest approaches to addressing lifestyle factors causing GI symptoms.
3. Discuss the role of pharmacy team to support people with GI symptoms to self-care

Moderator:
- Manjiri Gharat, FIP Vice-President, India

Panellists:
- Ruth Rudling, Advanced Clinical Pharmacist for Specialty Medicines, Mid Yorkshire NHS Trust (MYHT), UK
- Anja St. Clair-Jones, Consultant Pharmacist Gastroenterology, University Hospitals Sussex, UK

Traditionally, the distribution of medicines to consumers has been organized through heavily regulated networks of physical pharmacies. The strict regulation of market structure has been in place to ensure the safety, accessibility and affordability of medicines, but it has also limited competition in the pharmacy sector. Nowadays, the regulation of pharmacies differs between countries, and this has created different market conditions for online pharmacies to operate.

In some countries the online sales of medicines have grown considerably during the recent years as consumers have become more accustomed to e-commerce. More lately the Covid-19 pandemic has dramatically shaped the e-commerce landscape. Due to the pandemic, the demand for online services of pharmacies has increased significantly in many countries. It is also likely that this has changed preferences for some consumers permanently and demand should therefore remain at a higher level in the future.

Increased cooperation between countries in developing regulation of online pharmacies is needed, according to the report, “Online pharmacy operations and distribution of medicines”, which will be published by the International Pharmaceutical Federation (FIP) on December 8th, 2021.

Moderator:
- Lars-Åke Söderlund, FIP Vice President, Executive Advisor, Apoteket AB, Sweden, Sweden

Co-Moderator:
- Sarah Dineen-Griffin, Lecturer, Health Service Management, Charles Stuart University, Australia

Panellist:
- Catherine Duggan, FIP CEO, The Netherlands
- Manjiri Gharat, Principal, K. M. Kundnani Pharmacy Polytechnic, India
- Sari Westermarck, Community pharmacist, Finland
- Jacqueline Surugue, Immediate Past Vice President FIP, France
- Nadia Al Mazrouei, Assistant Professor, Sharjah University, United Arab Emirates (UAE) 
- Eduardo Savio, President, Pharmaceutical Forum of the Americas, Uruguay
- John Jackson, President, Western Pacific Pharmaceutical Forum, Australia  
- Prosper Hiag, President, African Pharmaceutical Forum, Cameroon
- Tanniru Narayana, President, Indian Pharmaceutical Association, India
- Jaime Acosta-Gómez, Community Pharmacist and pharmacy owner, Farmacia Acosta, Spain

Summary
There is variability across the globe in the provision of universal healthcare. Self-care is the ability to maintain and improve individual’s health, prevent or limit diagnosed illnesses, and address self-treatable conditions. Self care is not no care and it is not necessarily practised in isolation. It may involve support and advice from others, such as expert pharmacy teams.  This event discusses how self-care can contribute to Universal Health Coverage from the perspectives of providers of healthcare services and public and patients. 

Aim: To discuss the perspectives of providers of healthcare services and the people accessing them about how self-care can contribute to universal health coverage.

Learning objectives: 

• Explain the extent to which self-care is embedded in healthcare systems;
• Discuss cultural approaches to enabling self-care as part of UHC, such as healthy lifestyles;
• List healthcare systems and patients/public’s needs for enabling self-care;
• Discuss the contribution of localised self-care delivery to UHC

Moderator:
 - Sham Moodley, Community Pharmacist, Member of the FIP Community Pharmacy Section, South Africa

Panellist:
- K Srinath Reddy, President, Public Health Foundation of India, India
- Jacqueline Bowman-Busato, Co-Founder, Belgian Private Foundation Pate Adiposité Adipositas Pacte, Belgium
- Dave Burrows, CEO and CTO, Damibu, UK

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals

This is an important event in the region due to the presence of international, well-known, keynote speakers and the participation and support of international associations. The event will bring together regulatory and science key professionals as well pharmaceutical industry and academia to share experiences, perspectives, insights and the latest regulation and technical development.

The Theme of this conference is the regulatory aspects related to bioequivalence and the objective is to discuss current international trends and updates in bioequivalence assessment, biowaivers, bioanalytics, dissolution and procedures. 

The conference will provide a unique opportunity for regulators, members of the pharmaceutical industry and academics in MENA region to interact with international experts and obtain information on current and innovative trends in the areas of bioequivalence, biowaivers, bioanalysis, and dissolution testing.

In October-2021, FIP-UNITWIN Regional Workshops brought FIP’s member academic institutions, professional organisations, key pharmacy stakeholders and guests across all regions together to co-create a roadmap to advance pharmacy and pharmaceutical sciences in their region through educational partnerships. At the FIP-UNITWIN Global Summit on pharmaceutical education, participants will;

1. Learn about their regions’ roadmap on advancing pharmacy and pharmaceutical sciences education;
2. Explore FIP’s global call to action on pharmaceutical education to support it across their regions and countries;
3. Discover country cases and next steps of the FIP-UNITWIN Centres for Excellence programme

Chairs:
-Catherine Duggan, FIP CEO
-Ralph J. Altiere, FIPEd Chair

Speakers:
-Dominique Jordan, FIP President
-Luis Lorenco, FIP Professional Secretary
-Giovanni Pauletti, FIP Scientific Secretary
-Pierre Moreau, FIP AIM Chair

Panellists:
-Anne Anderson Vice Chair, UK National Commission for UNESCO
-Toyin Tofade, President-Elect of the FIP Academic Pharmacy Section (AcPS) & FIP AIM Advisory Committee Member
-Silvana Nair Leite, FIP AIM Advisory Committee member
-Lilian Azzopardi, AIM Advisory Committee member
-Aukje Mantel-Teeuwisse,FIP Digital Health in Pharmacy Education Report Chair, FIP Technology Forum Member, FIP APS Executive Committee Member
-Beom-Jin Lee, AIM Advisory Committee member
-Rajani Shakya, AIM Advisory Committee member
-Mohamad Rahal, AIM Advisory Committee member
-Rula Darwish, Academic Pharmacy Section Exco
-Paul J. Gallagher, AIM Advisory Committee member
-Mwila Chiluba, AIM Advisory Committee member
-Yahya Choonara, AIM Advisory Committee member
-Arinola Joda, Asst. Secretary/Editor in Chief, APF

Facilitators:
-Nilhan Uzman, FIP Lead for education policy and implementation
-Ozge Ozer, FIP Educational Partnership Coordinator
-Alison Ubong Etukakpan, FIP Educational Partnership Coordinator

The Global Advanced development framework (GADF) was developed to support the professional development and recognition of the pharmacy workforce everywhere and the Global Competency Framework (GbCF) was developed by the FIP as a focused support structure for early career pharmacists.  This digital event seeks to create more awareness for the GADF and GbCF and to enable young pharmacists and pharmaceutical scientists have a better understanding of their structure.

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals

Summary

Pharmacy teams are increasingly supporting children and their carers with self-care. This webinar will focus particularly on appropriate management of choices of medicines and products to support children’s health, and the role of the pharmacist. A case study will be presented and the event will conclude with a panel discussion.

Aim: To identify how the community pharmacy team can support self-care of common health problems for children and their carers.

Learning objectives: 

1. Increase awareness of children’s health issues, how common they are, what impacts they have and how they can be managed;
2. Learn how to support carers and children with common health issues;
3. Discuss appropriate management in the choice of medicines and products.
4. Describe the role that pharmacist and their team can play in advising and educating carers and children so they can self-care.

Moderator:
Sarah Dineen-Griffin, Lecturer in health services management and leadership, Charles Sturt University, Australia

Panellist:
- Hadi Dassouki, Community Pharmacist, Lebanon
- Jack Collins, Postdoctoral Research Associate, The University of Sydney School of Pharmacy, Australia
- Joanne Crook, Consultant Pharmacist Paediatrics, Kings College Hospital, UK

EAHP, the European Association of Hospital Pharmacists, is pleased to invite you to our 2022 Annual Congress (https://www.eahp.eu/congresses), taking place from 23 to 25 March 2022 in Vienna, Austria.

"Hospital pharmacists – changing roles in a changing world" will be the theme for the presentations at our upcoming Congress in Vienna. During last year's virtual congress, we focused on digitalization and automation to improve future patient care. These new technologies found their way in to your daily practice or at least gave you inspiration for new projects. But these changes go beyond the hospital pharmacy and even beyond the hospital and healthcare; the whole world is evolving quickly which results in new needs and expectations from society. This year we will help you to determine and to explore the changing roles of hospital pharmacists in this evolving scene. This is an invitation to all of you to join us.

The EAHP team (https://www.eahp.eu/)

 Furthermore, the EAHP Congress is also an ideal time and place where to meet our colleagues, exchange our experience and find new professional connections and friends. Don't miss the opportunity!

Come to the 2022 FIP congress in Seville, Spain, where pharmacy practitioners, pharmaceutical scientists and educators from around the world will discuss and help you prepare for these new technologies that will empower our profession.

Previous industrial revolutions liberated humans from reliance on animal power, made mass production possible and brought digital capabilities to billions. This latest industrial revolution is, however, fundamentally different. It is characterised by a range of technologies that are fusing the physical, digital and biological worlds, impacting on all disciplines, economies and industries, and even challenging ideas about what it means to be human.

Digitalisation is already allowing the keeping of structured patient records, facilitating electronic prescribing, dispensing and administration of medicines, automating the handling of medicines in the supply chain, and providing tools for monitoring the efficacy and safety of medicines in use. Further advances will enable pharmacists to interact with patients through the creation of a common platform for accessing data and information in new, more efficient way.